Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). The Company announced via press release dated June 16, 2022 (the “Default Announcement”) that it … [Read more…]
